Comments
Loading...
Fate Therapeutics (FATE) Forecast
NewsEarningsFate Therapeutics (FATE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestFate Therapeutics (NASDAQ:FATE) Stock Quotes, Forecast and News Summary
Fate Therapeutics Stock (NASDAQ: FATE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Fate Therapeutics (FATE) stock?
You can purchase shares of Fate Therapeutics (NASDAQ:FATE) through any online brokerage.
Who are Fate Therapeutics (FATE) competitors?
Other companies in Fate Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Invizyne Technologies (NASDAQ:IZTC), Innate Pharma (NASDAQ:IPHA) and Inozyme Pharma (NASDAQ:INZY).
What is the forecast, or price target, for Fate Therapeutics (FATE) stock?
Fate Therapeutics has a consensus price target of $8.05.
What is the current price for Fate Therapeutics (FATE)?
The stock price for Fate Therapeutics (NASDAQ: FATE) is $1.57 last updated December 26, 2024 at 12:41 PM EST.
Does Fate Therapeutics (FATE) pay a dividend?
There are no upcoming dividends for Fate Therapeutics.
When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?
Fate Therapeutics’s Q4 earnings are confirmed for Monday, February 24, 2025.
Is Fate Therapeutics (FATE) going to split?
There is no upcoming split for Fate Therapeutics.
What sector and industry does Fate Therapeutics (FATE) operate in?
Fate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.